Real-world comparison of progression-free survival and time to next therapy in 761 patients with newly diagnosed multiple myeloma.
- DOI
- 10.1182/bloodadvances.2025018655
- Published
- 2026 Feb 24
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025018655,
title = {Real-world comparison of progression-free survival and time to next therapy in 761 patients with newly diagnosed multiple myeloma.},
author = {Mian H and Arribas M and Fonseca R and Mutterback E and Shahid O and Gouda R and Pond GR and Visram A},
year = {2026},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2025018655},
url = {https://doi.org/10.1182/bloodadvances.2025018655}
}RIS
TY - JOUR TI - Real-world comparison of progression-free survival and time to next therapy in 761 patients with newly diagnosed multiple myeloma. AU - Mian H AU - Arribas M AU - Fonseca R AU - Mutterback E AU - Shahid O AU - Gouda R AU - Pond GR AU - Visram A PY - 2026 JO - Blood advances DO - 10.1182/bloodadvances.2025018655 UR - https://doi.org/10.1182/bloodadvances.2025018655 ER -
APA
H, M., M, A., R, F., E, M., O, S., R, G., GR, P., & A, V. (2026). Real-world comparison of progression-free survival and time to next therapy in 761 patients with newly diagnosed multiple myeloma.. Blood advances. https://doi.org/10.1182/bloodadvances.2025018655
Source records
- pubmed · retrieved 2026-09-26T21:04:44.136Z